A Consent Decree By Other Means?
This article was originally published in RPM Report
Executive Summary
Here is the list of manufacturing commitments Roche/Genentech accepted to receive approval of Kadcyla (T-DM1, ado-trastuzumab emtansine). FDA's redactions are designated with brackets.